Antibody directed against gastrin-releasing peptide precursor and use thereof
AssigneeAdvanced Life Science Institute, Inc.
InventorKatsumi Aoyagi
Life of this patent
Estimating the term…
Loading patent…
AssigneeAdvanced Life Science Institute, Inc.
InventorKatsumi Aoyagi
Estimating the term…
Disclosed is a novel method for determination of ProGRP which is free from problems such as the dispersion in the values of measurements and operational constraints such as handling of a test sample. A method for the determination of a gastrin-releasing peptide precursor or a digest thereof using at least two different antibodies each of which can recognize a peptide comprising the partial amino acid sequence starting from amino acid residue 40 and ended at amino acid residue 75 in the amino acid sequence depicted in SEQ ID NO:1; and a method for the determination of a gastrin-releasing peptide precursor and/or a digest thereof using at least two different antibodies each of which can recognize a peptide comprising the partial amino acid sequence starting from amino acid residue 40 and ended at amino acid residue 79 in the amino acid sequence depicted in SEQ ID NO:1. The methods have such advantages that a detection sensitivity comparable to that in a conventional determination method can be achieved, that it is easy to handle a sample after the sample is collected, and that a highly reproducible measurements can be obtained.
A method for determining a gastrin-releasing peptide precursor or a digest thereof, comprising contacting a test sample with two or more different antibodies which recognize a peptide comprising a partial amino acid sequence consisting of amino acids 40 to 75 of the amino acid sequence shown in SEQ ID NO:2, wherein at least one antibody is a monoclonal antibody which is produced by hybridoma 3D6-2 deposited under Accession No. FERM BP-08669.
A method for determining a gastrin-releasing peptide precursor or a digest thereof, comprising contacting a test sample with two or more different antibodies which recognize a peptide comprising a partial amino acid sequence consisting of amino acids 40 to 79 of the amino acid sequence shown in SEQ ID NO:2, wherein at least one antibody is a monoclonal antibody which is produced by hybridoma 3D6-2 deposited under Accession No. FERM BP-08669.
Dependencies are inferred from the claim text.